BlackRock Inc. purchased a new position in shares of Siga Technologies Inc. (NASDAQ:SIGA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 4,186,282 shares of the company's stock, valued at approximately $15,238,000. BlackRock Inc. owned 5.84% of Siga Technologies as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of SIGA. Deutsche Bank AG purchased a new position in Siga Technologies during the 2nd quarter valued at about $138,000. Bank of New York Mellon Corp acquired a new stake in shares of Siga Technologies during the second quarter worth about $967,000. State of Wyoming acquired a new stake in shares of Siga Technologies during the second quarter worth about $56,000. Empowered Funds LLC acquired a new stake in shares of Siga Technologies during the first quarter worth about $162,000. Finally, Quantinno Capital Management LP grew its holdings in shares of Siga Technologies by 58.0% in the first quarter. Quantinno Capital Management LP now owns 31,589 shares of the company's stock valued at $169,000 after purchasing an additional 11,592 shares in the last quarter. 55.40% of the stock is owned by institutional investors and hedge funds.
Siga Technologies Stock Up 0.6%
Shares of Siga Technologies stock opened at $3.23 on Friday. Siga Technologies Inc. has a 52-week low of $2.83 and a 52-week high of $9.45. The company has a 50 day moving average of $3.29 and a 200 day moving average of $4.39. The company has a market capitalization of $232.08 million, a P/E ratio of -64.60 and a beta of 0.97.
Siga Technologies (NASDAQ:SIGA - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.17 EPS for the quarter. Siga Technologies had a negative net margin of 5.19% and a negative return on equity of 1.55%. The company had revenue of $41.00 million for the quarter.
Analysts Set New Price Targets
Separately, Weiss Ratings cut Siga Technologies from a "sell (d+)" rating to a "sell (d)" rating in a research note on Tuesday, August 11th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of "Sell".
Get Our Latest Stock Report on Siga Technologies
About Siga Technologies
(
Free Report)
Siga Technologies, Inc NASDAQ: SIGA is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of medical countermeasures for public health emergencies and biological threats. The company's flagship product, TPOXX® (tecovirimat), is the first and only antiviral approved by the U.S. Food and Drug Administration for the treatment of smallpox. Siga has entered into procurement and development contracts with U.S. government agencies, including the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense, to supply TPOXX® for the Strategic National Stockpile.
Founded in 2002, Siga has built a pipeline of therapies targeting high-consequence pathogens such as smallpox, plague and other potential biothreat agents.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Siga Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Siga Technologies wasn't on the list.
While Siga Technologies currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
